Group Leader

Req ID:  100871
Location: 

Leiden, NL, 2333 CR

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

 

Charles River are pleased to announce an exciting opportunity for a talented, highly motivated manager at our state-of-the-art drug discovery site in Leiden. 


The appointed Group Leader will be a key member of the operational management team providing strong scientific, operational and strategic leadership to multiple teams at the Leiden site of our Biology department. Besides line management of direct reports, the successful applicant will lead scientific project teams, as well as be involved in business development activities. As part of the management team, the candidate will contribute to building and managing the Leiden Biology team to support further growth of the business. The ideal candidate will have experience in managing people and will have a proven track record of successful project management in a drug discovery setting. As a positive role model, a key attribute will be a demonstrated ability to push boundaries and inspire others.


Responsibilities
•    Provide line management of up to 10 direct reports (scientific staff) in accordance with company directions and policies, being responsible for performance reviews, succession planning, development and training of team members
•    Contribute to the management and performance of the Leiden Biology team by taking on selected responsibilities (e.g. recruitment, operational projects etc.)
•    Provide independent project leadership of scientific project teams aimed at maintaining client satisfaction as well as delivery on project objectives and financials, demonstrating strategic decision making and creative problem solving
•    Ensure a high level of scientific standard is maintained on projects involved
•    Communicate clearly and effectively, interfacing positively with direct reports, clients, colleagues and key stakeholders
•    Secure new business opportunities, working independently with business development to prepare scientific proposals and present to potential new clients

 

Candidate Profile
•    You have at least 5 years of experience as a team leader in an industrial setting, ideally within a Pharma/biotech or CRO environment
•    We can offer a gross salary in the range of EUR 63 – 70.000 and other benefits
•    Excellent interpersonal skills with the ability to motivate multiple teams and to inspire others
•    Familiar with all aspects of drug discovery (e.g. HTS, biomarker strategies and development of appropriate screening cascades) and experience in complex in vitro biology, such as use of primary cells, stem cells or 3D cultures in drug discovery. Experience with new therapeutic modalities such as cell therapy, gene therapy or biologics (e.g. proteins, antibodies, ASOs) is a plus.
•    Able to work across various therapeutic areas in order to apply these skills to ongoing and new projects. A flexible and dynamic approach towards achieving client-based objectives and meeting challenging deadlines is required, as is the ability to communicate confidently and concisely with clients via teleconferences, presentations and written reports.
•    Ample experience in successfully leading project teams, planning & managing resources and finances and influencing within and outside of own project
•    Sound scientific judgement which impacts the direction and delivery of projects or departmental initiatives
•    Able to write high quality project proposals to challenging deadlines 

 

About Discovery
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 350 patents and 80 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.

 

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

 

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

 

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.